Computational techniques to study breast cancer scaffolds for antiangiogenesis: a review

Robin Singh1, Neha Gupta2, Raj Luxmi1

  • 1Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India.

Abstract

Insights

Computational methods like virtual screening and molecular docking accelerate the discovery of novel antiangiogenic compounds for breast cancer treatment. These techniques identify promising drug candidates targeting key tumor growth pathways.

Area of Science:

  • * Computational chemistry and bioinformatics.
  • * Drug discovery and development.
  • * Cancer research, specifically breast cancer therapeutics.

Background:

  • * Breast cancer is a major cause of female mortality globally.
  • * Tumor angiogenesis is critical for breast cancer progression, presenting a therapeutic target.
  • * Computational drug discovery offers powerful tools for identifying and optimizing anticancer agents.

Purpose of the Study:

  • * To review the application of computational techniques in discovering antiangiogenic breast cancer drugs.
  • * To evaluate methods like virtual high-throughput screening (VHTS) and molecular docking.
  • * To assess the role of these methods in targeting angiogenesis-related pathways.

Main Methods:

  • * Systematic literature search of databases (Google Scholar, PubMed, ScienceDirect, TCGA).
  • * Qualitative synthesis of 38 studies (2015-2025) on computational approaches.
  • * Focus on computational targeting of VEGFR-2, STAT3, HER2, PI3K/Akt, and SphK1 signaling.

Main Results:

  • * VHTS, molecular docking, ADMET prediction, molecular dynamics, MM-GBSA/MM-PBSA, and QSAR modeling aid hit identification and lead optimization.
  • * Promising antiangiogenic compounds identified include triazolopyrazine derivatives, curcumin, liquiritin, and novel STAT3 inhibitors.
  • * These compounds showed favorable binding characteristics and antiangiogenic potential.

Conclusions:

  • * Computational approaches are effective in identifying and optimizing antiangiogenic breast cancer drug candidates.
  • * Identified compounds demonstrate significant potential for advancing breast cancer therapy.
  • * The integration of computational methods is crucial for future drug discovery in oncology.